Category : Search result: India pharmaceutical licensing


Govt Audits 700+ Cough Syrup Makers, Tests 19 Samples

Indian government intensifies scrutiny on pharmaceutical sector, auditing 700+ cough syrup manufacturers. Health Ministry reveals 19 drug samples collected for testing amid child safety concerns. Read the full report.

Sudeep Pharma IPO Subscribed 94 Times

Sudeep Pharma's ₹895 crore IPO witnessed massive demand, subscribed 94 times. QIB portion booked 213x. Shares may list at a 14% premium. Key details inside.

Balaxi Pharma Soars 10% Despite 47% Yearly Loss

Balaxi Pharmaceuticals shares surged 10% to ₹39.5 in intraday trade Friday, defying market weakness. However, the stock remains down 47.42% YTD with retail investors facing significant wealth erosion.

Hvax Technologies H1 FY26 Income Jumps 35%

Hvax Technologies announces impressive 35% growth in total income for H1 FY26, reaching ₹5.95 crore. The company shows strong financial performance with significant profit improvements.

India Urges Russia to Fast-Track Export Approvals

India requests Russia to expedite approvals for Indian exporters in marine, pharmaceutical sectors during Moscow talks. Bilateral trade targets $100B by 2030. Key discussions ahead of Putin's December visit.

Lincoln Pharma Aims for Rs 1000 Crore Revenue

Lincoln Pharmaceuticals Ltd announces ambitious plan to achieve Rs 1000 crore revenue within three years through strategic expansion and new product launches. Read more about their growth strategy.

Granules India Gets USFDA Approval for Hyderabad Plant

Granules Life Sciences receives USFDA approval for new Hyderabad facility to manufacture diabetes drug Metformin HCL. Capacity: 10 billion tablets annually. Read more about this pharmaceutical milestone.

Sun Pharma: US Tariff Clarity & Q2 FY26 Outlook

Sun Pharma investors await Q2 FY26 results with cautious optimism as US tariff clarity emerges. Discover how import duties and market dynamics could impact India's pharmaceutical giant.

Curis Lifesciences IPO: 17x Subscription on Day 1

Curis Lifesciences' NSE SME IPO witnesses massive investor response with 17.36 times subscription on Day 1. Discover GMP trends, price band details, and why this pharma stock is creating buzz.

Trump: Deal Reached to Lower Weight Loss Drug Prices

Former President Donald Trump reveals groundbreaking agreement with pharmaceutical giants to dramatically reduce costs of popular weight loss medications, promising relief for millions struggling with obesity.

Page 2 of 4